Maggot excretions inhibit biofilm formation on biomaterials
about
Mechanisms of maggot-induced wound healing: what do we know, and where do we go from here?Traditional Therapies for Skin Wound HealingMaggot debridement therapy as primary tool to treat chronic wound of animalsMaggot excretions affect the human complement systemMaggot debridement therapy: a systematic review.Sterilization of Chrysomya putoria (Insecta: Diptera: Calliphoridae) eggs for use in biotherapy.Polymicrobial interactions: impact on pathogenesis and human disease.Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical MaggotsAntibiotic-decorated titanium with enhanced antibacterial activity through adhesive polydopamine for dental/bone implant.Complement activation and inhibition in wound healing.Larval therapy applied to a large arterial ulcer: an effective outcome.Antibiofilm agents and implant-related infections in orthopaedics: where are we?Multiple actions of Lucilia sericata larvae in hard-to-heal wounds: larval secretions contain molecules that accelerate wound healing, reduce chronic inflammation and inhibit bacterial infection.TIME management by medicinal larvae.Effect of negative pressure on growth, secretion and biofilm formation of Staphylococcus aureus.Histological patterns in healing chronic wounds using Cochliomyia macellaria (Diptera: Calliphoridae) larvae and other therapeutic measures.Selective Antibiofilm Effects of Lucilia sericata Larvae Secretions/Excretions against Wound Pathogens.A randomized controlled trial of larval therapy for the debridement of leg ulcers: results of a multicenter, randomized, controlled, open, observer blind, parallel group study.A metagenomic assessment of the bacteria associated with Lucilia sericata and Lucilia cuprina (Diptera: Calliphoridae).First Record of Larval Secretions of Cochliomyia macellaria (Fabricius, 1775) (Diptera: Calliphoridae) Inhibiting the Growth of Staphylococcus aureus and Pseudomonas aeruginosa.Biocompatibility of antimicrobials to maggot debridement therapy: medical maggots Lucilia sericata (Diptera: Calliphoridae) exhibit tolerance to clinical maximum doses of antimicrobials.Pharmacological Properties of the Medical Maggot: A Novel Therapy Overview.
P2860
Q21284686-982EB99B-0322-4495-984C-36D4293E860AQ26748518-14CC3112-F524-4ECF-9F78-CF31EF85A5A2Q26749465-819270AF-6440-4FAD-9487-F6AFFDAC97E4Q28278228-6C6EF406-F102-4518-8862-9761823147B3Q34452208-84800119-7313-4BD6-98EC-5F9CB67ED968Q35423089-97BE2D41-520E-4CB5-B0AE-7F5C4412D347Q35666253-278B549F-2BFD-4634-BD25-1461DBCE6E57Q36784772-5E1FEE61-9E7D-406D-954C-F5C356166C83Q37735397-52DC8D57-D4F1-40D6-A98B-703A1E96CA90Q38076419-9922CB06-7CAF-4A60-AB3B-FDFE9A7E234AQ38099158-B6614CAF-99A0-4387-9BE8-0AC6ECFA923EQ38107655-1EFD0E02-E7E7-478D-941E-490FCD3A6E71Q38152372-1DC642AB-8247-4747-9E39-345E31A151CAQ38548116-A1F55DE5-1E35-4484-BF2A-1E79A5497305Q41053246-C21704EB-5D75-4C40-81AA-F2D830EC48B4Q41295893-79C16D92-2139-4B96-ACC1-C4D9B4022E58Q41464670-26185FAF-DE68-446B-ACCB-4FF27804F280Q42631297-D4955275-3C20-4898-920B-B7FEF2C4300CQ46826650-9893383F-0146-427A-8B8B-7D5561B6EDF3Q51785752-AD4876A5-38F5-47F8-816C-30B039244602Q52744402-4DF6B7F9-D075-4A27-8697-0C0881902F0BQ55265628-953C9210-4289-43BD-B433-24FAF0961E42
P2860
Maggot excretions inhibit biofilm formation on biomaterials
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Maggot excretions inhibit biofilm formation on biomaterials
@en
type
label
Maggot excretions inhibit biofilm formation on biomaterials
@en
prefLabel
Maggot excretions inhibit biofilm formation on biomaterials
@en
P2093
P2860
P1476
Maggot excretions inhibit biofilm formation on biomaterials
@en
P2093
Christina M J E Vandenbroucke-Grauls
Gerrolt N Jukema
Gwendolyn Cazander
Marco W J Schreurs
Mariëlle C van de Veerdonk
P2860
P2888
P304
P356
10.1007/S11999-010-1309-5
P407
P577
2010-03-23T00:00:00Z